Proxima
PrivateLast Round
Seed
Jan 13, 2026
Total Funding Raised
$80.33M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Proxima operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in January 2026.
Proxima is a biotechnology company that provides an AI-driven drug discovery platform for proximity therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proxima Comparables
Compare Proxima with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rezo Therapeutics | 82% | |
| Orionis Biosciences | 80% | |
| Insitro | 79% |
For institutional investors. Book with your work email.
Proxima Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 13, 2026 | ||||
| Series B | Jan 12, 2026 | ||||
| Pre Seed | Oct 10, 2024 | ||||
| Grant | May 24, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Proxima Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Seed |
| Braidwell | Seed |
| Magnetic Ventures | Seed |
| NVentures | Seed |
| Yosemite | Seed |
| Alexandria Venture Investments | Seed |
| NVentures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 57% MoM, from 5.1K to 8K.
- Apr 1, 2026
Launched Neo-1, an all-atom foundation model for molecular generation.
For institutional investors. Book with your work email.
Proxima Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Proxima's valuation, stock price, and market status.
Is Proxima a public or private company?
Proxima is a private company.
What is the current stock price of Proxima?
Proxima is a private company, so its shares have no public market price. Caplight tracks Proxima's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Proxima worth (valuation)?
Valuation information for Proxima is not publicly available.
Can I buy Proxima stock?
Proxima shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Proxima's last funding round?
Proxima's most recent funding round was Seed on January 13, 2026.
Who are the main investors in Proxima?
Key investors in Proxima include DCVC (Data Collective).
Will Proxima IPO soon?
No public IPO plans have been announced for Proxima.
How can I track Proxima secondary market activity?
Caplight tracks bids, offers, and trades in Proxima's shares on secondary markets.